L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinsons disease.
性状
Solid
IC50 & Target[1][2]
Human Endogenous Metabolite
体内研究(In Vivo)
L-DOPA (20 mg/kg; oral) reduces Rotenone-induced motor dysfunction.L-DOPA (10, 30, 50, 70, and 100 mg/kg; oral) reverses tactile, cold and heat allodynia in neuropathic rat without any side effect in sprague-Dawley rats.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.Anima
运输条件
Room temperature or refrigerated transport.
储存方式
4°C, stored under nitrogen;*该产品在溶液状态不稳定,建议您现用现配,即刻使用。;
ClinicalTrial
结构分类
PhenolsPolypheno
溶解度数据
体外研究:0.1 M HCL : 20 mg/mL(101.43 mM;ultrasonic and warming and adjust pH to 2 with HCl and heat to 60°C)H2O : 1 mg/mL(5.07 mM;Need ultrasonic)